176 related articles for article (PubMed ID: 15735697)
1. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells.
Chen C; Sun X; Ran Q; Wilkinson KD; Murphy TJ; Simons JW; Dong JT
Oncogene; 2005 May; 24(20):3319-27. PubMed ID: 15735697
[TBL] [Abstract][Full Text] [Related]
2. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
Chen C; Sun X; Guo P; Dong XY; Sethi P; Cheng X; Zhou J; Ling J; Simons JW; Lingrel JB; Dong JT
J Biol Chem; 2005 Dec; 280(50):41553-61. PubMed ID: 16223724
[TBL] [Abstract][Full Text] [Related]
3. Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway.
Chen ZY; Wang X; Zhou Y; Offner G; Tseng CC
Cancer Res; 2005 Nov; 65(22):10394-400. PubMed ID: 16288030
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation.
Oishi Y; Manabe I; Tobe K; Tsushima K; Shindo T; Fujiu K; Nishimura G; Maemura K; Yamauchi T; Kubota N; Suzuki R; Kitamura T; Akira S; Kadowaki T; Nagai R
Cell Metab; 2005 Jan; 1(1):27-39. PubMed ID: 16054042
[TBL] [Abstract][Full Text] [Related]
5. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
6. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
[TBL] [Abstract][Full Text] [Related]
7. Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway.
Chen C; Zhou Z; Guo P; Dong JT
FEBS Lett; 2007 Mar; 581(6):1124-30. PubMed ID: 17320083
[TBL] [Abstract][Full Text] [Related]
8. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.
Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism.
del Rincón SV; Guo Q; Morelli C; Shiu HY; Surmacz E; Miller WH
Oncogene; 2004 Dec; 23(57):9269-79. PubMed ID: 15516986
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
[TBL] [Abstract][Full Text] [Related]
11. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer.
Chen C; Bhalala HV; Qiao H; Dong JT
Oncogene; 2002 Sep; 21(43):6567-72. PubMed ID: 12242654
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein.
Kim JH; Sohn SY; Benedict Yen TS; Ahn BY
Biochem Biophys Res Commun; 2008 Feb; 366(4):1036-42. PubMed ID: 18155658
[TBL] [Abstract][Full Text] [Related]
13. Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells.
Carelli S; Di Giulio AM; Paratore S; Bosari S; Gorio A
J Cell Physiol; 2006 Aug; 208(2):354-62. PubMed ID: 16619240
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-proteasome pathway function is required for lens cell proliferation and differentiation.
Guo W; Shang F; Liu Q; Urim L; Zhang M; Taylor A
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2569-75. PubMed ID: 16723472
[TBL] [Abstract][Full Text] [Related]
15. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
[TBL] [Abstract][Full Text] [Related]
16. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
17. c-Fos degradation by the ubiquitin-proteasome proteolytic pathway in osteoclast progenitors.
Ito Y; Inoue D; Kido S; Matsumoto T
Bone; 2005 Dec; 37(6):842-9. PubMed ID: 16172035
[TBL] [Abstract][Full Text] [Related]
18. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.
Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW
Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211
[TBL] [Abstract][Full Text] [Related]
19. The C-terminus of MIP-T3 protein is required for ubiquitin-proteasome-mediated degradation in human cells.
Guo CW; Liu G; Xiong S; Ge F; Fuse T; Wang YF; Kitazato K
FEBS Lett; 2011 May; 585(9):1350-6. PubMed ID: 21510943
[TBL] [Abstract][Full Text] [Related]
20. Proteasome mediated degradation of Id-1 is associated with TNFalpha-induced apoptosis in prostate cancer cells.
Ling MT; Kwok WK; Fung MK; Xianghong W; Wong YC
Carcinogenesis; 2006 Feb; 27(2):205-15. PubMed ID: 16123120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
